281 related articles for article (PubMed ID: 20888839)
1. Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.
Lucas GM
Life Sci; 2011 May; 88(21-22):948-52. PubMed ID: 20888839
[TBL] [Abstract][Full Text] [Related]
2. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.
Mellins CA; Havens JF; McDonnell C; Lichtenstein C; Uldall K; Chesney M; Santamaria EK; Bell J
AIDS Care; 2009 Feb; 21(2):168-77. PubMed ID: 19229685
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the association between Addiction Severity Index and depression with adherence to anti-retroviral therapy among HIV infected patients.
Paydary K; Ekhtiari H; Noori M; Rad MV; Hajiabdolbaghi M; SeyedAlinaghi S
Infect Disord Drug Targets; 2015; 15(3):177-83. PubMed ID: 26411558
[TBL] [Abstract][Full Text] [Related]
4. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure.
Merlin JS; Westfall AO; Raper JL; Zinski A; Norton WE; Willig JH; Gross R; Ritchie CS; Saag MS; Mugavero MJ
J Acquir Immune Defic Syndr; 2012 Oct; 61(2):164-70. PubMed ID: 22766967
[TBL] [Abstract][Full Text] [Related]
5. A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.
Kuchinad KE; Hutton HE; Monroe AK; Anderson G; Moore RD; Chander G
BMC Res Notes; 2016 Apr; 9():229. PubMed ID: 27103162
[TBL] [Abstract][Full Text] [Related]
6. The unrealized potential of addiction science in curbing the HIV epidemic.
Volkow ND; Baler RD; Normand JL
Curr HIV Res; 2011 Sep; 9(6):393-5. PubMed ID: 21999774
[TBL] [Abstract][Full Text] [Related]
7. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
Celentano DD; Lucas G
Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
[TBL] [Abstract][Full Text] [Related]
8. Substance use: impact on adherence and HIV medical treatment.
Gonzalez A; Barinas J; O'Cleirigh C
Curr HIV/AIDS Rep; 2011 Dec; 8(4):223-34. PubMed ID: 21858414
[TBL] [Abstract][Full Text] [Related]
9. Social networks of substance users with HIV infection: application of the Norbeck Social Support Scale.
Kelly PJ; Ramaswamy M; Li X; Litwin AH; Berg KM; Arnsten JH
West J Nurs Res; 2012 Aug; 34(5):621-34. PubMed ID: 21890719
[TBL] [Abstract][Full Text] [Related]
10. Triple diagnosis: dual diagnosis and HIV disease, Part 1.
Douaihy AB; Jou RJ; Gorske T; Salloum IM
AIDS Read; 2003 Jul; 13(7):331-2, 339-41. PubMed ID: 12889451
[TBL] [Abstract][Full Text] [Related]
11. Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.
Brust JC; Litwin AH; Berg KM; Li X; Heo M; Arnsten JH
AIDS Res Hum Retroviruses; 2011 May; 27(5):535-41. PubMed ID: 20854173
[TBL] [Abstract][Full Text] [Related]
12. Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail.
Chitsaz E; Meyer JP; Krishnan A; Springer SA; Marcus R; Zaller N; Jordan AO; Lincoln T; Flanigan TP; Porterfield J; Altice FL
AIDS Behav; 2013 Oct; 17 Suppl 2(0 2):S118-27. PubMed ID: 23673792
[TBL] [Abstract][Full Text] [Related]
13. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric Disorders, Antiretroviral Medication Adherence and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults.
Bucek A; Leu CS; Benson S; Warne P; Abrams EJ; Elkington KS; Dolezal C; Wiznia A; Mellins CA
Pediatr Infect Dis J; 2018 Jul; 37(7):673-677. PubMed ID: 29227462
[TBL] [Abstract][Full Text] [Related]
15. Barriers and Facilitators of HIV Care Engagement: Results of a Qualitative Study in St. Petersburg, Russia.
Kuznetsova AV; Meylakhs AY; Amirkhanian YA; Kelly JA; Yakovlev AA; Musatov VB; Amirkhanian AG
AIDS Behav; 2016 Oct; 20(10):2433-2443. PubMed ID: 26767534
[TBL] [Abstract][Full Text] [Related]
16. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
Chander G; Himelhoch S; Moore RD
Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
[TBL] [Abstract][Full Text] [Related]
17. Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence.
Wang EA; McGinnis KA; Long JB; Akgün KM; Edelman EJ; Rimland D; Wang KH; Justice AC; Fiellin DA
Am J Addict; 2015 Mar; 24(2):178-184. PubMed ID: 25662297
[TBL] [Abstract][Full Text] [Related]
18. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
[TBL] [Abstract][Full Text] [Related]
19. The urgency of providing comprehensive and integrated treatment for substance abusers with HIV.
Volkow ND; Montaner J
Health Aff (Millwood); 2011 Aug; 30(8):1411-9. PubMed ID: 21821558
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.
Lucas GM; Gebo KA; Chaisson RE; Moore RD
AIDS; 2002 Mar; 16(5):767-74. PubMed ID: 11964533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
